What is Avenzo Therapeutics worth?
$590.0Mlast known valuation
Avenzo Therapeutics last raised $47.2M in its Early Stage VC (Aug 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Avenzo Therapeutics
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Aug 2025 | Early Stage VC | $47.2M | ▮ | ▮ |
| Sep 2022 | Later Stage VC | $385.9M | ▮ | ▮ |
How Avenzo Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Avenzo Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Avenzo Therapeutics worth?
- Avenzo Therapeutics's last known valuation is $590.0M.
- How much has Avenzo Therapeutics raised?
- Avenzo Therapeutics has raised $445.9M in total funding across 2 recorded rounds.
- When did Avenzo Therapeutics last raise?
- Avenzo Therapeutics last raised in Aug 2025 (Early Stage VC), raising $47.2M.